Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06124014 · ClinicalTrials.gov registry record · NA
CES for the Treatment of GAD in Young Adults
A NA study of Generalized Anxiety Disorder, sponsored by Electromedical Products International.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT06124014: Completed NA study of Generalized Anxiety Disorder, sponsored by Electromedical Products International.
NCT06124014 is a NA study of Generalized Anxiety Disorder that has completed, run by Electromedical Products International. The registered enrollment target is 130 participants, below the 212-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06124014, a NA study of Generalized Anxiety Disorder, has completed, sponsored by Electromedical Products International.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to study cranial electrotherapy stimulation (CES) to determine its effects on symptoms of anxiety in people with generalized anxiety disorder (GAD) between the ages of 18 - 21 years of age.
Primary Outcome
Change in HAM-A between six-week follow-up (FU1) and baseline (D1); minimum value is 0, maximum value is 56. Higher scores indicate worse outcome.
Conditions Studied
Interventions
- DEVICE At-Home Stimulation
Study Locations (1)
North Carolina
- Carolina Center for Neurostimulation - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2026-01-21 |
| Phase | NA |
What the finished NCT06124014 record still lists
NCT06124014 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 212-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Generalized Anxiety Disorder appearing as the primary indexed condition, and to 1 intervention - of which At-Home Stimulation is the first listed.
NCT06124014 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06124014 about?
NCT06124014 is a clinical study titled "CES for the Treatment of GAD in Young Adults". The purpose of this research study is to study cranial electrotherapy stimulation (CES) to determine its effects on symptoms of anxiety in people with generalized anxiety disorder (GAD) between the ages of 18 - 21 years of age.
What is the current status of trial NCT06124014?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2024-01-26. Estimated completion is 2026-01-21.
What conditions does trial NCT06124014 study?
This clinical trial studies the following conditions: Generalized Anxiety Disorder.
What interventions are being tested in trial NCT06124014?
The interventions under investigation include: At-Home Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06124014?
This trial is sponsored by Electromedical Products International, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06124014 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Generalized Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06124014's enrollment target sits among peer trials
130 25th of 48 higher than 24 of 48 other Generalized Anxiety Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Generalized Anxiety Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
RECRUITING · NA
-
Massage for GAD: Neuroimaging and Clinical Correlates of Response
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI